Posted by Michael Wonder on 25 Mar 2021
Statement on COVID-19 vaccine supply at Anagni plant in Italy
24 March 2021 - AstraZeneca would like to clarify a number of inaccurate statements relating to COVID-19 Vaccine AstraZeneca doses at the Anagni plant in Italy.
There are no exports currently planned other than to COVAX countries. There are 13m doses of vaccine waiting for quality control release to be dispatched to COVAX as part of the Company’s commitment to supply millions of doses to low-income countries. The vaccine was made outside the European Union (EU) and brought to the Anagni plant to be filled into vials. The EU fully supports supplying low-and middle-income countries through the COVAX facility.
